N6-Methyl-2’-O-(2-methoxyethyl) adenosine

N6-Methyl-2’-O-(2-methoxyethyl) adenosine

• UNSPSC Description: N6-Methyl-2’-O-(2-methoxyethyl) adenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
• Target Antigen: Nucleoside Antimetabolite/Analog
• Type: Oligonucleotides
• Related Pathways: Cell Cycle/DNA Damage
• Applications: Cancer-programmed cell death
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/n6-methyl-2-o-2-methoxyethyl-adenosine.html
• Solubility: 10 mM in DMSO
• Smiles: O[C@H]1[C@@H](OCCOC)[C@H](N(C=N2)C3=C2C(NC)=NC=N3)O[C@@H]1CO
• Molecular Weight: 339.35
• References & Citations: [1]Man S, et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500.|[2]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported